{"Title": "Is survival and neurodevelopmental impairment at 2 years of age the gold standard outcome for neonatal studies?", "Year": 2015, "Source": "Arch. Dis. Child. Fetal Neonatal Ed.", "Volume": "100", "Issue": 1, "Art.No": null, "PageStart": null, "PageEnd": null, "CitedBy": 25, "DOI": "10.1136/archdischild-2014-306191", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84919884365&origin=inward", "Abstract": null, "AuthorKeywords": null, "IndexKeywords": ["Child, Preschool", "Developmental Disabilities", "Disabled Children", "Humans", "Infant, Premature", "Infant, Premature, Diseases", "Outcome Assessment (Health Care)"], "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 1, "EID": "2-s2.0-84919884365", "SubjectAreas": [["Pediatrics, Perinatology and Child Health", "MEDI", "2735"], ["Obstetrics and Gynecology", "MEDI", "2729"]], "AuthorData": {"7006171979": {"Name": "Marlow N.", "AuthorID": "7006171979", "AffiliationID": "60022148", "AffiliationName": "Neonatal Medicine, UCL EGA Institute for Women's Health"}}}